Skip to content

Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Taiwan

Identification and Characterization of the Bacteria Causing Acute Otitis Media (AOM) Episodes in Young Children in Taiwan

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01072227
Enrollment
10
Registered
2010-02-22
Start date
2010-07-31
Completion date
2011-04-30
Last updated
2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Otitis Media

Keywords

Non-typeable Haemophilus Influenzae, Acute Otitis Media, Streptococcus Pneumoniae, Etiology

Brief summary

The purpose of the study is to identify the bacterial aetiology of Acute Otitis Media episodes in young children aged \>= 3 months to \< 5 years in Taiwan

Interventions

PROCEDURESample Collection

Tissue

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Age: \>= 3 months and \< 5 years at the time they are seen by the pediatrician or ear, nose and throat specialist. The subject becomes ineligible on the fifth birthday. * Onset of signs and symptoms of acute otitis media within 72 hours: * One of the functional or general signs of otalgia (, conjunctivitis, fever and either * Paradise's criteria or * Spontaneous otorrhea of less than 1 day. * Written informed consent obtained from parent or legally acceptable representative prior to study start.

Exclusion criteria

* Hospitalized during the diagnosis of acute otitis media. * Onset of otorrhea greater than 1 day prior to enrolment. * Otitis externa, or otitis media with effusion. * Presence of a transtympanic aerator. * Systemic antibiotic treatment received for a disease other than acute otitis media in the 72 hours prior to enrolment. * Receiving antimicrobial prophylaxis for recurrent acute otitis media. * Provision of prescribing antibiotics by ear, nose and throat specialist and Pediatricians for acute otitis media before sample collection. * Intended or planned prescription of antibiotic by pediatrician or ear, nose and throat specialist prior to the completion of study specified procedures during the enrolment visit.

Design outcomes

Primary

MeasureTime frame
Proportion of H. influenzae, S. pneumoniae and other bacterial pathogensAverage duration: 12 months

Secondary

MeasureTime frame
Antimicrobial susceptibility of H. influenzae, S. pneumoniae and Moraxella catarrhalisAverage duration: 12 months
Proportion of treatment failure of Acute Otitis Media (AOM) and of recurrent AOMAverage duration: 12 months
Distribution of H. influenzae and S. pneumoniae serotypes.Average duration: 12 months
Occurrence of H. influenzae in AOM cases with treatment failure and in new AOM cases without treatment therapyAverage duration: 12 months
Occurrence of H. influenzae in AOM cases vaccinated with a pneumococcal vaccine.Average duration: 12 months
Occurrence of spontaneous otorrheaAverage duration: 12 months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026